Supplementation of fibrinogen in acquired bleeding disorders: Experience, evidence, guidelines, and licences

British Journal of Anaesthesia

Volumn 109, Issue 2, 2012, Pages 135-137

  Ranucci, M ^a   Solomon, C ^b  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b SALK University Hospital   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ACQUIRED BLEEDING DISORDER; ANTICOAGULANT THERAPY; ARTERIAL THROMBOEMBOLISM; BLEEDING DISORDER; CRYOPRECIPITATE; DRUG EFFICACY; DRUG SAFETY; HUMAN; LICENSING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUPPLEMENTATION;

EID: 84863896147     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aes227     Document Type: Editorial

References (26)

1. Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 2010; 105: 116-21
2. Levy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012; 114: 261-74
3. Tauber H, Innerhofer P, Breitkopf R, et al. Prevalence and impact of abnormal ROTEMw assays in severe blunt trauma: results of the 'Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study'. Br J Anaesth 2011; 107: 378-87
4. Sorensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol 2010; 149: 834-43
5. Bevan DH. Cardiac bypass haemostasis: putting blood through the mill. Br J Haematol 1999; 104: 208-19 (Pubitemid 29083326)
6. Snyder CW, Weinberg JA, McGwin G Jr, et al. The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma 2009; 66: 358-62
7. Wallis JP. Transfusion-related acute lung injury (TRALI)-underdiagnosed and under-reported. Br J Anaesth 2003; 90: 573-6 (Pubitemid 36592328)
8. Shander A, Javidroozi M, Ozawa S, Hare GM. What is really dangerous: anaemia or transfusion? Br J Anaesth 2011; 107(Suppl. 1): i41-59
9. Etemadrezaie H, Baharvahdat H, Shariati Z, et al. The effect of fresh frozen plasma in severe closed head injury. Clin Neurol Neurosurg 2007; 109: 166-71 (Pubitemid 46073399)
10. Stanworth SJ, Hunt BJ. The desperate need for good-quality clinical trials to evaluate the optimal source and dose of fibrinogen in managing bleeding. Crit Care 2011; 15: 1006
11. Ozier Y, Hunt BJ. Against: fibrinogen concentrate for management of bleeding: against indiscriminate use. J Thromb Haemost 2011; 9: 6-8
12. Yang L, Stanworth S, Hopewell S, Doree C, Murphy M. Is freshfrozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion Advance Access published on 18 January 2012, doi: 10.1111/j.1537-2995.2011.03515.x
13. Kozek-Langenecker S, Sorensen B, Hess JR, Spahn DR. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care 2011; 15: R239
14. Gö rlinger K, Dirkmann D, Hanke AA, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, singlecenter cohort study. Anesthesiology 2011; 115: 1179-91
15. Clinical Trials.gov international registry for clinical trials. Available from http://www.clinicaltrials.gov/(accessed 12 March 2012)
16. Rossaint R, Bouillon B, Cerny V, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010; 14: R52
17. Ahmed S, Johnson S, Varadkar S, et al. Does fibrinogen concentrate reduce blood products use in major obstetric haemorrhage? Arch Dis Child Fetal Neonatal Ed 2011; 96: Fa77-78
18. Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ. Guidelines on the management of massive blood loss. Br J Haematol 2006; 135: 634-41 (Pubitemid 44674073)
19. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009; 145: 24-33
20. Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO). Final Minutes of the Thirteenth Meeting. Regus London Victoria, London, UK. 18 January 2011. Available from http://www.dh.gov.uk/prod-consum-dh/groups/dh- digitalassets/@dh/@ab/documents/digitalasset/dh-128084.pdf (accessed 5 April 2012)
21. Novoseven Summary of Product Characteristics. Last updated 13 February 2012. Available from http://www.medicines.org.uk/emc/medicine/21171/SPC/ (accessed 5 May 2012)
22. Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91: 944-82
23. Gill R, Herbertson M, Vuylsteke A, et al. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 2009; 120: 21-7
24. Guidance for Industry Responding to Unsolicited Requests for Off- Label Information About Prescription Drugs and Medical Devices. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation Research (CBER), Center for Veterinary Medicine (CVM), Center for Devices and Radiological Health (CDRH). December 2011. Available from http://www.fda. gov/downloads/Drugs/GuidanceComplianceRegulatory Information/Guidances/ UCM285145.pdf (accessed 15 February 2012)
25. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sorensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008; 101: 769-73
26. Kozek-Langenecker S, Sorensen B, Hess J, Spahn DR. Emotional or evidence-based medicine: is there a moral tragedy in haemostatic therapy? Crit Care 2011; 15: 462